Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Talen Energy Corp V.TLN


Primary Symbol: TLN

Talen Energy Corporation owns and operates power infrastructure in the United States. The Company produces and sells electricity, capacity, and ancillary services in wholesale power markets in the United States, primarily in PJM and WECC, with its generation fleet principally located in the Mid-Atlantic region of the United States and Montana. The majority of its generation is produced at its zero-carbon nuclear and lower-carbon gas-fired facilities. Its generation capacity is 10,665 megawatts (MW). Its segments include PJM and Other. The PJM segment is engaged in electricity generation, marketing activities, commodity risk and fuel management within the PJM RTO or ISO markets and comprises Susquehanna and Talen’s natural gas and coal generation facilities. Its Other segment includes the operating and marketing activities of Talen Montana’s proportionate share of the Colstrip Units in the WECC market, the operating activities of Nautilus, and other development activities.


NDAQ:TLN - Post by User

Bullboard Posts
Post by Everswanon May 31, 2009 1:08pm
70 Views
Post# 16031140

Exposing Pepmoron dishonest nature

Exposing Pepmoron dishonest nature
The following paper is the supporting article authority on his moronic views:

https://www.tau.ac.il/lifesci/departments/neuro/members/kloog/documents/blum.pdf

Here is a link to the very interesting scientific paper "Tailoring Raspathway: Inhibitor combination for cancer therapy". This paper waspublished in late 2005 and you will see that drug combinationtargetting Ras pathway is nothing new. You will also see that Iressaand Traveca have a long story of combination with drugs aiming at Raspathway.


Yeah stupid Pepmoron, the long history they have with RAS makes them perfect buyers. They understand the technology and can better appreciated it. They understand how 4601 is superior in design to what they have.


So after reading this paper, if you can understand what is written in it.

This arrogant little moron is calling you all too stupid to understand... Unbelievable...


The same author, wrote about RAS inhibitor and GBM!

https://mct.aacrjournals.org/content/5/9/2337.full.pdf+html?sid=1f4df6f6-c9f3-4e7c-8e34-ed13c75c5b5f

These results show that resistance to apoptosis
in glioblastoma multiforme can be abolished by a single
Ras inhibitor, which targets both survivin, a critical inhibitor
of apoptosis, and the intrinsic mitochondrial apoptotic
machinery.

Two years later, Thallion gets exactly what the paper would have hoped for.
Thallion basically got the same results for 4601 and presented data at AACR 2008:

https://www.thallion.com/docs/publications/20.AACR2008-1485.pdf



Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse